SANOFICONRSanofi Consumer Healthcare India Limited Forensic Risk Analysis

Pharmaceuticals
Risk ClassStable
Market Cap₹9,917 Cr
Primary DriverGovernance
Flagium AI Risk Score
Stable structural profile. Financial profile appears resilient.
5 / 100
-5 QoQ
Improving
Sentinel Insight

Financial profile remains stable for now. Pressure is receding in governance. This indicates that forensic pressure is currently receding. Risk levels are improving.

6.1th %ile (Sector)Accel: +0 Qtrs
Updated2026-06-02
Market View
₹4,670.9▲1.84%
PeriodQ4 FY26

Score Waterfall
Absolute contribution points of each forensic pillar to the final risk score. Derived from: Sector Baseline + Active Penalties - Mitigation Buffers.

Stability Adjustment
+5.0 pts
Final Composite Risk5 / 100

Investment Risk Thesis

Historical Trend

Current risk score has risen from 0 → 5 over 12 quarters.

Expected Direction
🟢 Improving
Primary Deterioration Drivers
  • Margin Compression
  • Working Capital Expansion
What to Watch Next Quarter
  • Working capital efficiency
  • Operating profit margins

Active Risk Objects (2)

CriticalHigh
Working Capital Expansion
💧 Liquidity & CoverageAnnualActive for 2 Years
More Detail
Impact Weight10/15
MomentumAccelerating
Last SignalQ3 FY2026
Working capital expansion detected: Receivable days increased by 48.5%.

"Working capital cycle is stretching dangerously. This is putting severe strain on daily operations."

Margin Compression
📊 Earnings QualityAnnualActive for 1 Years
More Detail
Impact Weight15/15
MomentumAccelerating
Last SignalQ2 FY2026
Operating margin declined by 2.5 bps YoY for two consecutive quarters.

"Early signs of margin erosion. Input costs are beginning to eat into core profits."

Risk Trajectory
Historical 12-quarter risk trend (Q-11 to Q0) followed by a 2-quarter predictive funnel (Q+1, Q+2).
Loading Chart
Resilience Matrix
Diagnostic benchmarking comparing structural sensitivity and risk buffers against sector medians.
MetricValuevs SectorSignal
Volatility (σ)3.917.70✅ RESILIENT
Sensitivity (ε_s)11.00✅ RESILIENT
Escalation Prob.5%5%✅ NEUTRAL
Safety Buffer+61.0+47.0✅ RESILIENT
Forensic Benchmark Context: Pharmaceuticals (n=99 peers)

Correlation Analysis
Visualizing the relationship between stock price movement and structural risk objects.

Loading Chart
Share Price
Risk Score (0-100)
Market Performance
₹4,670.9(+1.84%)
1M Divergence-4.22%
1 Week+0.34%
1 Month-1.95%
6 Months-0.06%
1 Year-13.98%
2 Year-6.39%
3 Year-6.39%
Sector Average (1M)+2.27%
Sentinel Forensic Assessment
ALGORITHMIC RISK PROFILE • NON-ADVISORY

The structural architecture is currently robust. Capital resilience buffers in governance remain well-maintained against forensic benchmarks. Systematic scans of structural transparency and audit trails confirm the absence of material structural stress. Initial structural recovery is visible; monitor for a sustained return to resilience.

SANOFICONR • MARKET STRUCTURE

Stage 1 — Accumulation

The company is in a foundational phase. Risk metrics are stabilizing as the company builds a base for potential future fundamental improvement.

Stage Transition Prob.4%
Trend QualityEarly Base
Phase Progression
Phase Progression Score30%
Readiness LabelLow (Early Base Consolidation)
Probability of Advancing4%
CoinTree Momentum
Composite Z-Score-0.1690σ
Weakening momentum trend
Universe Rank
A cross-sectional rank of this stock's composite momentum score compared to all other tracked equities in the universe. A rank of #1 of 1035 means it has the strongest overall price momentum in the market.
#1343 of 2716
Top 49.45% in momentum strength
Timeframe Sparklines
1W+0.3%
1M-1.9%
6M-0.1%
Weinstein Indicators
150 DMA₹4,499.64
200 DMA₹4,628.97
150 DMA Slope-0.2007%Declining
Relative Strength+5.43%Leading
Relative Turnover (RTR)0.6179
ParticipationWeak

PEER COMPARISON

Ranked comparison against sector peers

This company appears relatively stable compared to the Sector Mean (19).
ABBOTINDIAABBOTINDIA
0 Risk
Sector %ile0th
Delta0
Active Flags0
Accel+0
Governance

Stable

SANOFICONRSanofi Consumer Healthcare India Limited
5 Risk
Sector %ile6th
Delta-5
Active Flags2
Accel+0
Governance

Stable

AARTIDRUGSAarti Drugs Limited
19 Risk
Sector %ile51th
Delta-5
Active Flags11
Accel+0
Competitive Position

Stable

AAREYDRUGSAarey Drugs & Pharmaceuticals Limited
23 Risk
Sector %ile63th
Delta-5
Active Flags20
Accel+0
Balance Sheet Stress

Watch

* Peer comparison is based on risk signals, not valuation or returns.

Risk Profiles

Solvency
10100th %ile
VS Sector Median (8.5)
Governance
10100th %ile
VS Sector Median (8.5)
Earnings Quality
10100th %ile
VS Sector Median (8.5)
Balance Sheet Stress
10100th %ile
VS Sector Median (8.5)
Competitive Position
10100th %ile
VS Sector Median (8.5)
Growth Sustainability
10100th %ile
VS Sector Median (8.5)

Deterioration Timeline

2026

Working Capital Expansion

2026

Margin Compression

2025

Working Capital Expansion

Key Financials (INR Cr)

PeriodRevenueNet ProfitOCFDebt
FY2025897240277-
FY2024738181439-